Evaluation and Treatment of Patients with Major Depressive Disorder: Are We Considering All the Options?

Megan Maroney, PharmD
Published Online: Wednesday, August 22, 2012
This activity is supported by an educational grant from Mylan Specialty, LP.
 
Evaluation and Treatment of Patients with Major Depressive Disorder: Are We Considering All the Options?
 
Megan Maroney, PharmD

Clinical Assistant Professor
Ernest Mario School of Pharmacy
Rutgers University
Piscataway, New Jersey
Clinical Psychiatric Pharmacist
Monmouth Medical Center
Long Branch, New Jersey

 

 
Megan Maroney, PharmD, has no financial relationships with commercial interests to disclose related to this activity.
 
Pharmacy Times Office of Continuing Professional Education Planning Staff
 
Judy V. Lum, MPA, Ann C. Lichti, CCMEP, and Elena Beyzarov, PharmD, have no relevant affiliations or financial relationships with commercial interests to disclose related to this activity.
 
Pharmacy Times Editorial Staff
 
Jennifer Whartenby and David Allikas have no relevant affiliations or financial relationships with commercial interests to disclose related to this activity.
 
The peer reviewer of this activity has no relevant financial relationships with commercial interests to disclose related to this activity.
 

 
Educational Objectives
 
Upon completion of this educational activity, participants should be able to:
  1. Review the pathophysiology and epidemiology of major depressive disorder (MDD), atypical depression, and treatment-resistant depression.
  2. Address challenges of treating depression, including safety concerns (eg, adverse effects, drug–food interactions), noncompliance, relapse, and inadequate response to antidepressant therapy.
  3. Discuss current and emerging antidepressant treatments, including strategies used for typical and treatment-resistant depression.
  4. Formulate counseling strategies to improve patient outcomes in depression.
Target audience: Pharmacists
Type of activity: Knowledge
Release date: August 10, 2012
Expiration date: August 10, 2014
Estimated time to complete activity: 2 hours
Fee: This lesson is free online
 
Click here to view this activity.

Related Articles
Patient profiles should be reviewed for drugs that may cause or exacerbate incontinence.
Patients who were treated for persistent depression after an acute coronary syndrome experienced improved outcomes during treatment, but worsened outcomes after treatment ended.
A report found wide variations in use of medications to treat emotional and behavioral problems by gender, age, race and ethnicity, household income, and insurance type.
Latest Issues
$auto_registration$